Bio-Rad’s Droplet Digital PCR (ddPCR)-powered liquid biopsy was presented during the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta
New isotype-specific secondary antibodies promise improved signal detection and specificity in imaging
Innovative workflow promises highly sensitive detection of lncRNAs by qPCR and ddPCR to help researchers “overcome challenges associated with lncRNA expression analysis”
New range for use in drug level monitoring assays and biosimilar development
Automation-ready flow cytometer enables biomarker discovery and phenotypic screening
Published in the peer-reviewed journal mAbs, the paper introduces complex-specific antibodies for pharmacokinetic analysis of biotherapeutics
Droplet digital PCR’s effectiveness in detecting minimal residual disease was highlighted by researchers at 60th ASH annual meeting & exposition
An evening of stimulating talks about the automated preparation and sorting of viable neurons from adult mouse brain for functional assays and single cell sequencing.
Life science research and clinical diagnostics provider launches anti-pembrolizumab and anti-nivolumab antibodies to monitor drug levels in cancer patients
StarBright Blue 520 Fluorescent Secondary Antibodies offer best sensitivity among fluorescent dye–labeled secondary antibodies that emit in the green channel
The immunoassay is the market’s first validated high-performance multiplex screening panel
New antibodies used to support research into the treatment of ulcerative colitis and Crohn’s disease
Bio-Rad’s lncRNA Workflow includes highly sensitive and specific qPCR arrays and individual assays to assess more than 23,000 human lncRNA targets, aiding in lncRNA discovery and validation across many research areas
Bio-Rad shares its expertise to help perfect fluorescence-based protein detection and quantitation
Collector Offers Flexibility and Capacity for Applications from Discovery to Scale Up
Dysbiosis success triggers further investment and development agreement for additional microbiome tests beyond GA-map™ dysbiosis Test
QXDx BCR-ABL %IS kit achieves highest sensitivity for detecting disease remission in patients with chronic myeloid leukemia
